Sermorelin
This IPS-listed option is reviewed privately during consultation. Details are reviewed privately during consultation.
Back to peptide library
Growth-hormone peptide education
Ipamorelin / Sermorelin
A dual growth-hormone support conversation built around Ipamorelin's ghrelin-receptor signaling and Sermorelin's GHRH pathway support for clinician-guided vitality, recovery, sleep, and body-composition goals.
Dual GH pathways Sermorelin IPS listings Ipamorelin related blends Clinical screening required
Overview
What is the IPA/Sermorelin blend?
a / Ipamorelin and Sermorelin blend designed to support natural growth-hormone signaling through complementary pathways.
IPS does not currently show one exact Ipamorelin/Sermorelin blend card in the available list. IPS does list Sermorelin options and several Ipamorelin-containing blends, so consultation should confirm what is available and clinically appropriate.
Common program goals
- Discuss growth-hormone signaling and vitality support
- Review sleep quality, recovery, training load, and body composition
- Screen IGF-1, glucose markers, medications, and contraindications
- Coordinate protocol timing with sleep, nutrition, and exercise habits
- Track labs, tolerance, energy, recovery, and clinical response over time
IPS access
Available related IPS listings.
These entries come from the IPS access available list. Final route, timing, duration, and candidacy depend on consultation, availability, and clinician judgment.
Sermorelin /
This IPS-listed option is reviewed privately during consultation. Details are reviewed privately during consultation.
CJC-1295 / Ipamorelin
This IPS-listed option is reviewed privately during consultation. Details are reviewed privately during consultation.
Mechanism
Two complementary GH-support concepts.
Ipamorelin is commonly discussed around selective ghrelin-receptor activation, while Sermorelin is commonly discussed around the growth hormone-releasing hormone pathway. IPS keeps the conversation tied to labs, symptoms, safety, and realistic goals.
Ipamorelin
Often discussed for selective growth-hormone release with less cortisol or prolactin activity than older secretagogues.
Sermorelin
A GHRH analog discussed for supporting pulsatile pituitary growth-hormone signaling.
Sleep and recovery
Protocols are commonly timed with nighttime recovery goals and normal GH rhythm discussions.
Clinical monitoring
Baseline and follow-up review may include IGF-1, glucose markers, symptoms, and response.
Process
How GH-support care works at IPS.
Baseline Review
Review sleep, recovery, body composition, training, fatigue, medications, and hormone history.
Clinical Screening
Screen IGF-1, glucose concerns, cancer history, pituitary history, pregnancy-related factors, and lab needs.
Protocol Design
If appropriate, your clinician reviews available listings, timing, schedule, storage, and monitoring.
Follow-Up
Follow-up tracks tolerance, sleep, recovery, labs, body-composition trends, and whether changes are needed.
Safety & candidacy
Growth-hormone signaling needs medical context.
IPS reviews cancer history, pituitary conditions, diabetes or glucose concerns, sleep apnea risk, edema, medication use, pregnancy-related factors where applicable, and whether lab work is needed before discussing therapy.
Common effectsInjection-site irritation, water retention, tingling, hunger changes, headache, fatigue, or sleep changes may occur.
MonitoringBaseline and follow-up labs may be appropriate depending on goals, risk factors, and protocol length.
ContraindicationsActive cancer, uncontrolled diabetes, certain pituitary conditions, or untreated sleep apnea may change candidacy.
No guaranteesResponse varies, and this page is educational rather than a promise of hormone optimization.
Questions
Frequently asked.
Does IPS list one IPA/Sermorelin blend?
The current available list does not show one exact Ipamorelin/Sermorelin blend card. It does list Sermorelin and related Ipamorelin-containing blends.
How is this blend described?
It describes a / dual peptide blend using Ipamorelin and Sermorelin for complementary growth-hormone support.
Can this replace hormone evaluation?
No. Growth-hormone-related symptoms and therapy decisions should be evaluated by a qualified clinician with appropriate screening.
Can it be combined with other peptides?
Possibly, but combinations should be reviewed against labs, goals, medications, and safety considerations.
Contact
Ask IPS about Ipamorelin and Sermorelin eligibility.
Complete the form and IPS will follow up about consultation scheduling and next steps.
Medical note This page is educational and is not intended to diagnose, treat, cure, or prevent disease. Peptide decisions require consultation with a qualified clinician.